The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Authors: Tetyana P Buzhdygan, PhD; Brandon J DeOre, BS; Abigail Baldwin-Leclair, BS; Trent A Bullock, BS, MA; Hannah McGary, BS; Jana A Khan, BS; Roshanak Razmpour, BS; Jonathan F Hale, BS, MA; Peter A Galie, PhD; Raghava Potula, PhD; Allison M Andrews, PhD; Servio H Ramirez, PhD
Disclaimer of Proprietary Rights: www.andrewslaboratory.com may contain proprietary and confidential information including trademarks, service marks and patents protected by intellectual property laws and international intellectual property treaties. Andrewslaboratory.com authorizes you to view and make a single copy of portions of its content for offline, personal, non-commercial use. Our content may not be sold, reproduced, or distributed without our written permission. Any third-party trademarks, service marks and logos are the property of their respective owners. Any further rights not specifically granted herein are reserved.
